Literature DB >> 10457532

Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus.

U L Mullins1, G Gianutsos, A S Eison.   

Abstract

Recent evidence suggests that a novel serotonin receptor 5-HT7 localized in the hypothalamus downregulates in response to treatment with the antidepressant fluoxetine (Sleight et al. 1995). This receptor has also been implicated in the regulation of circadian rhythms (Lovenberg et al. 1993). Here, we show that several agents administered in a profile consistent with activity at the 5-HT7 receptor produce significant functional Fos immunoreactivity in the suprachiasmatic nucleus (SCN), an effect reduced upon chronic exposure. Furthermore, binding studies demonstrate that chronic administration of Fos-inducing agents produces a neuroadaptive downregulation of the 5-HT7 receptor in the hypothalamus. The current studies extend the previous observations to include several pharmacologically distinct antidepressants. In addition, these studies provide further evidence to support the role of the 5-HT7 receptor in the mechanism of antidepressant action and in the regulation of circadian rhythms controlled by the SCN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457532     DOI: 10.1016/S0893-133X(99)00041-X

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  27 in total

1.  High-affinity interactions of ligands at recombinant guinea pig 5HT7 receptors.

Authors:  R E Wilcox; J E Ragan; R S Pearlman; M Y Brusniak; R M Eglen; D W Bonhaus; T E Tenner; J D Miller
Journal:  J Comput Aided Mol Des       Date:  2001-10       Impact factor: 3.686

Review 2.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

3.  Expression of 5-HT7 receptor mRNA in the hamster brain: effect of aging and association with calbindin-D28K expression.

Authors:  Marilyn J Duncan; Kathleen M Franklin
Journal:  Brain Res       Date:  2007-01-20       Impact factor: 3.252

Review 4.  Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia.

Authors:  Dennis H Kim; Matthew J Maneen; Stephen M Stahl
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

5.  Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.

Authors:  Isabelle Rauly-Lestienne; Elisa Boutet-Robinet; Marie-Christine Ailhaud; Adrian Newman-Tancredi; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-05       Impact factor: 3.000

6.  Zimelidine decreases seizure susceptibility in stressed mice.

Authors:  D Pericić; D S Strac; J Vlainić
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

7.  Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT₇ receptors.

Authors:  Brenda B García-Iglesias; María E Mendoza-Garrido; Gabriel Gutiérrez-Ospina; Claudia Rangel-Barajas; Martha Noyola-Díaz; José A Terrón
Journal:  Neuropharmacology       Date:  2013-03-28       Impact factor: 5.250

Review 8.  The 5-HT(7) receptor in learning and memory.

Authors:  Amanda J Roberts; Peter B Hedlund
Journal:  Hippocampus       Date:  2011-04-11       Impact factor: 3.899

9.  Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species.

Authors:  Francisco J Martín-Cora; Angel Pazos
Journal:  Br J Pharmacol       Date:  2003-12-01       Impact factor: 8.739

10.  The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

Authors:  Gor Sarkisyan; Amanda J Roberts; Peter B Hedlund
Journal:  Behav Brain Res       Date:  2010-01-25       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.